Grant McFadden

Boston Medical Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

83h-index24.1kcitations732works4.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(343), Herpesvirus Infections and Treatments(218), Poxvirus research and outbreaks(184), interferon and immune responses(119), Cancer Research and Treatments(75)

Publications728 total

Virus-derived serpin reduces immuno-coagulopathic damage in murine colitis by targeting the urokinase-type plasminogen activator receptor (uPAR) and complement
Scientific Reports·2025· 1 citedOpen Access
Evolutionary Variation of Poxvirus Genome Architecture
2025Open Access
Virus-derived Serpin Reduces Immuno-coagulopathic Damage in Murine Colitis by Targeting the urokinase-type Plasminogen Activator Receptor (uPAR) and Complement
2025Open Access
Creation of a 4‐view cardiac exam for assessment of ultrasound competency in pre‐clerkship medical students
Anatomical Sciences Education·2025
Poxvirus attack of anti-viral defense pathways unleashes an effector-triggered NF-κB response
2025Open Access
Effect of Exportin 1/XPO1 Nuclear Export Pathway Inhibition on Coronavirus Replication
Viruses·2025· 2 citedOpen Access
Divergence in poxvirus-encoded E3-like proteins can dictate poxvirus activation of cellular necroptosis
2024· 1 citedOpen Access
Adipose-Derived Stem Cells as Carrier of Pro-Apoptotic Oncolytic Myxoma Virus: To Cross the Blood–Brain Barrier and Treat Murine Glioma
International Journal of Molecular Sciences·2024· 4 citedOpen Access
Urokinase-Type Plasminogen Activator Receptor (uPAR) in Inflammation and Disease: A Unique Inflammatory Pathway Activator
Biomedicines·2024· 36 citedOpen Access
Correction for Rasmussen et al., “Virology—the path forward”
Journal of Virology·2024· 4 citedOpen Access
Systemic Dosing of Virus-derived Serpin Improves Survival and Immunothrombotic Damage in Murine Colitis
2024· 1 citedOpen Access
Virology—the path forward
Journal of Virology·2024· 9 citedOpen Access
Viral SERPINS—A Family of Highly Potent Immune-Modulating Therapeutic Proteins
Biomolecules·2023· 8 citedOpen Access
Viral anti‐inflammatory serpin reduces immuno‐coagulopathic pathology in <scp>SARS‐CoV</scp> ‐2 mouse models of infection
EMBO Molecular Medicine·2023· 12 citedOpen Access
FIGURE 2 from Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer
2023Open Access
Supplementary Table S1 from Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer
2023Open Access
FIGURE 5 from Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer
2023Open Access
Supplementary Figure S1 from Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer
2023Open Access
FIGURE 7 from Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer
2023Open Access
FIGURE 6 from Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer
2023Open Access
page 1 of 37Next →

Frequent Co-authors

John W. Barrett(13), Chris Upton(7), Joanne Macen(7), Helen Everett(5), Karen Mossman(5), Kathryn Graham(5), Alshad S. Lalani(5), James B. Johnston(4), Alexandra Lucas(4), Masmudur M. Rahman(4), Masmudur M. Rahman(4), Peter Forsyth(3), Ana Lemos de Matos(3), Marianne M. Stanford(3), Xiujuan Gao(3), John C. Bell(3), Patrick N. Nation(3), Eric Bartee(3), Morgan Sheng(2), Bruce T. Seet(2)